Novel Immunotherapy Shows Promise for Metastatic Renal Cell Carcinoma

John Schieszer reports that a Phase II study of 25 patients with newly diagnosed metastatic, clear cell, renal cell carcinoma is now suggesting that immunotherapy may be beneficial.
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters